Scandion Oncology

Overcoming cancer drug resistance

Navbar
  • Research & Development
    • Pipeline
    • Clinical Development
    • Science
      • Cancer drug resistance
      • Technology Platform
      • SCO-101
  • News & Press
    • Press releases
  • Investors
    • Share information
    • Financial calendar
    • Financial Reports
      • Annual reports
      • Interim reports
    • Presentations
    • Business development
    • Analyst Coverage
    • Prospectuses
      • Subscription warrants
      • Rights Issue 2024
      • Rights Issue 2022
      • Rights Issue 2020
      • Rights Issue 2019
      • Subscription Warrant (SCOL TO 1)
      • IPO 2018
    • Corporate governance
    • General meetings
Skip to content

Press releases

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
17 December 2019 CEO Nils Brünner is interviewed by Børsen Download Presentation Webcast Workbook
22 November 2019 BioStock article about Scandion Oncology Download Presentation Webcast Workbook
22 November 2019 Interview with CEO Nils Brünner in BioStock Download Presentation Webcast Workbook
30 October 2019 Scandion Oncology will present at Sedermeradagen on November 18, 2019, in Stockholm Download Presentation Webcast Workbook
4 October 2019 Peter Høngaard – our new Chairman of the Board – is portrayed and interview by BioStock Download Presentation Webcast Workbook
24 September 2019 Scandion Oncology will present on the Nordic Rise Launch Party Download Presentation Webcast Workbook
17 September 2019 Investor Lunch in Copenhagen on Oct 1st Download Presentation Webcast Workbook
1 July 2019 BioStock presentation of Scandion Oncology and the ongoing Rights Issue Download Presentation Webcast Workbook
27 June 2019 Unit Rights for shareholders Download Presentation Webcast Workbook
24 June 2019 Rights Issue investor presentation in Copenhagen on June 25 Download Presentation Webcast Workbook
21 June 2019 Scandion Oncology is now a member of Nordic Rise Download Presentation Webcast Workbook
21 June 2019 Presentation and interview from BioStock Live Download Presentation Webcast Workbook
  1. Frontpage
  2. Press releases
  3. News

About us

Research & Development

  • Research & Development
  • Pipeline
  • Clinical Development
  • Science

News & Press

  • Press releases
  • Other news
  • Image library items
  • Video library items

Investors

  • Investors
  • Share information
  • Financial Reports
  • Presentations
  • Analyst Coverage
  • Prospectuses
  • Corporate governance
  • Events

Scandion Oncology - The Cancer Drug Resistance Company

Our vision is to overcome cancer drug resistance in order to improve lives for cancer patients and their families

© Copyright 2022 - Scandion Oncology A/S | We use cookies to improve our services | Disclaimer: Market data could be delayed. Delivered by Cision.